SOMERSET, N.J., Jan. 18, 2016 (GLOBE NEWSWIRE) — MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced the release of its electronic prescribing app for the Apple Watch, one of the first electronic prescribing smartwatch apps available to U.S. healthcare providers.
MTBC’s Apple Watch app extends key components of its electronic prescribing app for iPhone users, known as MTBC iRx, to the Apple Watch. Users of the Apple Watch app can view patient refill request alerts and inbound patient communications on the watch and then leverage iRx to authorize refills, write new prescriptions, access patients’ medication histories and clinical support decision tools, and more.
“Our clients continue to be on the forefront of leveraging technology to streamline care and optimize health outcomes,” said Stephen Snyder, MTBC President. He continued, “Extending components of our highly-ranked mHealth and web-based ecosystem of applications to smartwatches marks an exciting evolution of our platform and we plan to build on this momentum in the year to come as we continue to extend the reach of our broader platform to smart watches and other wearable technology.”
MTBC’s Apple Watch app is the latest addition to its mHealth suite, which includes seven other apps. The most recently released app prior to MTBC’s electronic prescribing Apple Watch app was its ICD-10 converter app, which quickly seized and maintained the coveted rank of the most “popular” ICD-10 apps available in the Apple iTunes store.
To learn more about MTBC, please visit www.mtbc.com.
About Medical Transcription Billing, Corp.
Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
For additional information, please visit our website at www.mtbc.com.
This press release contains various forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “goals”, “intend”, “likely”, “may”, “plan”, “potential”, “predict”, “project”, “will” or the negative of these terms or other similar terms and phrases.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
Forward-looking statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors are including, but not limited to the company’s ability to manage growth; integrate acquisitions; effectively migrate and keep newly acquired customers and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission. Although we believe that the expectations reflected in the forward-looking statements contained in this press release are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
Press Contact: Amritpal Deol, Vice President and General Counsel MTBC email@example.com (732) 873-5133 x 141